Experiment 1014774

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

ELLIPTICINE

Alerts

DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
PLATELET ACTIVATING FACTOR RECEPTOR BINDING INHIBITION
Administration routeGASTRIC INTUBATION
OrganismEmpty organism
CitationANDREWS,JP: HILL,JT: GUARINO,AM: DAVIS,RO: GRAM,TE:. (1981). BIOAVAILABILITY AND ACUTE TOXICOLOGICAL EVALUATION OF ELLIPTICINE (NSC-71795). PHASE II. DOG STUDY.. 94()
Amount utilized
Compound isolated
Disease71% OF A SLOW-RELEASE FORMULATION EXCRETED IN FECES. ADDITIONAL PHARMACOKINETIC AND TOXICOLOGICAL DATA ARE GIVEN.
Number6
Qualitative resultACTIVE
AnimalDOG
Dose expressionDOSE
GenderFEMALE